AZN

GlaxoSmithKline PLC: The All-Weather Dividend Giant

moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]

GlaxoSmithKline PLC: The All-Weather Dividend Giant

moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]

AstraZeneca announces FDA approval of Bydureon Pen

moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]

US FDA approves Bydureon® Pen (exenatide extended-release for injectable suspension) for once-weekly treatment of adults with type 2 diabetes

[at noodls] – AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved the BYDUREON® Pen (exenatide extended-release for injectable suspension) 2 mg as an adjunct to diet and exercise … moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]

London pre-open: Ukraine to weigh heavily on FTSE

moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]